| 1 |
To KB,Napolitano LM. Closstridium difficile infection:update on diagnosis, epidemiology and treatment strategies[J]. Surg Infect, 2014, 15(5): 490-502.
|
| 2 |
谢和宾,曾鸿,尹柯, 等. 我国住院腹泻患者艰难梭菌感染率的荟萃分析[J]. 中华医院感染学杂志, 2017, 27(5): 961-964.
|
| 3 |
Lee JC,Hung YP,Lin HJ, et al. Clostridium difficile infections in medical intensive care units of a medical center in Southern Taiwan: variable seasonality and disease severity[J]. PLoS One, 2016, 11(8): e0160760.
|
| 4 |
陆晓凤,吴建祥,徐少毅, 等. 重症加强治疗病房腹泻患者艰难梭菌检测的敏感方法[J]. 中华危重病急救医学, 2015, 27(6): 525-526.
|
| 5 |
Persson S,Torpdahl M,Olsen KE. New multiplex PCR method for the detection of Clostridium difficile toxin A(tcdA) and toxin B (tcd B) and the binary toxin (cdtA/cdtB) genes applied to a Danish strain collection[J]. Clin Microbiol Infect, 2008, 14(11): 1057-1064.
|
| 6 |
周芬芬,吴湜,徐少华, 等. 艰难梭菌临床分离株5年前后耐药性变化[J].中国感染与化疗杂志, 2014, 14(2): 116-120.
|
| 7 |
曾勇彬,刘安超,李武, 等. ICU患者艰难梭菌分离培养与流行病学特征研究[J]. 中国微生态学杂志, 2018, 30(4): 424-437.
|
| 8 |
Griffiths D,Fawley W,Kachrimanidou M, et al. Multilocus sequence tying of Clostridium difficile[J]. J Clin Microbiol, 2010, 48(3): 770-778.
|
| 9 |
杨靖,李志荣,赵建宏, 等. 33株艰难梭菌临床分离株的多位点序列分型[J].中华检验医学杂志, 2013, 36(10): 920-925.
|
| 10 |
贾红兵,杨辉,杜鹏程, 等. 艰难梭菌临床分离株的毒素检测和MLST分型[J]. 中华微生物学和免疫学杂志, 2017, 37(4): 297-302.
|
| 11 |
Magill SS,Edwards JR,Bamberg W, et al. Multistate point-prevalence survey of health care-associated infections[J]. N Engl J Med, 2014, 370(13): 1198-1208.
|
| 12 |
刘元元,刘文恩,简子娟, 等. 住院腹泻患者艰难梭菌检测与分析[J]. 中国感染控制杂志, 2012, 11(4): 293-296.
|
| 13 |
张春莹,康梅,何超, 等. 艰难梭菌腹泻及实验室诊断[J]. 寄生虫病与感染性疾病, 2012, 10(2): 68-72.
|
| 14 |
徐亚青,邓敏. 难辨梭状芽孢杆菌医院感染的流行病学特征及感染控制现状分析[J]. 中华医院感染学杂志, 2013, 23(20): 5073-5075.
|
| 15 |
金慧,吴建浓,韦凌娅, 等. 艰难梭菌分离培养与病原学分子特征研究[J].浙江预防医学, 2014, 26(6): 602-603, 609.
|
| 16 |
王晶,李春辉,杜鹏程, 等. 中国部分地区艰难梭菌PCR-核糖体分型及毒素基因多态性研究[J]. 中国感染控制杂志, 2014, 13(1): 1-7.
|
| 17 |
Zahar JR,Schwebel C,Adrie C, et al. Outcome of ICU patients with Clostridium difficile infection[J]. Crit Care, 2012, 16(6): R215.
|
| 18 |
Yan Q,Zhang J,Chen C, et al. Multilocus sequence typing (MLST) analysis of 104 Clostridium difficile strains isolated from China[J]. Epidemiol Infect, 2013, 141(1): 195-199.
|
| 19 |
Chen YB,Gu SL,Wei ZQ, et al. Molecular epide-miology of Clostridium difficile in a tertiary hospital of China[J]. J Med Microbiol, 2014, 63(Pt 4): 562-569.
|
| 20 |
Markelov A,Livert D,Kohli H. Predictors of fatal outcome after colectomy for fulminant Clostridium difficile colitis: a 10-year experience[J]. Am Surg, 2011, 77(8): 977-980.
|
| 21 |
Kelly CP,LaMont JT. Clostridium difficile--more difficult than ever[J]. N Engl J Med, 2008, 359(18): 1932-1940.
|
| 22 |
Zacharioudakis IM,Zervou FN,Pliakos EE, et al. Colonization with toxinogenic C. difficile upon hospital adimission, and risk of infection: a systematic review and meta-analysis[J]. Am J Gastroenterol, 2015, 110(3): 381-390.
|
| 23 |
Loo VG,Bourgault AM,Poirier L, et al. Host and pathogen factors for Clostridium difficile infection and colonization[J]. N Engl J Med, 2011, 365(18): 1693-1703.
|
| 24 |
Wang R,Chen HX,Song LJ, et al. Molecular epidemiology and antimicrobial susceptibility of Clostridium difficile isolated from the Chinese People′s Liberation Army General Hospital in China[J]. Int J Infect Dis, 2018, 67(2): 86-91.
|
| 25 |
叶关胜,许文芳,金法祥, 等. 难辨梭菌相关性腹泻老年患者68例免疫功能分析[J/CD]. 中华危重症医学杂志（电子版）, 2015, 8(5): 318-320.
|
| 26 |
Dubberke ER,Reske KA,Yan Y, et al. Clostridium difficile-associated disease in a setting of endemicity:identification of novel risk factors[J]. Clin Infect Dis, 2007, 45(12): 1543-1549.
|
| 27 |
Owens RC Jr,Donskey CJ,Gaynes RP, et al. Antimicrobial-associated risk factors for Clostridium difficile infection[J]. Clin Infect Dis, 2008(46 Suppl 1): S19-S31.
|
| 28 |
Bignarde GE. Risk factors for Clotridium difficile infection[J]. J Hosp Infect, 1998, 40(1): 1-15.
|
| 29 |
Lessa FC,Mu Y,Bamberg WM, et al. Burden of Clostridium difficile infection in the United States[J]. N Engl J Med, 2015, 372(9): 825-834.
|
| 30 |
Gerding DN,Lessa FC. The epidemiology of Clostridium difficile infection inside and outside health care institutions[J]. Infect Dis Clin North Am, 2015, 29(1): 37-50.
|
| 31 |
Hensgens MP,Cooarhuis A,Dekkers OM, et al. Time interval of increased risk for Clostridium difficile infection after exposure to antibiotics[J]. J Antimicrob Chemother, 2012, 67(3): 742-748.
|
| 32 |
Keddis MT,Khanna S,Noheria A, et al. Clostridium difficile infection in patients with chronic kidney disease[J]. Mayo Clin Proc, 2012, 87(11): 1046-1053.
|
| 33 |
Surawicz CM,Brandt LJ,Binion DG, et al. Guidelines for diagnosis, treatment, and prevention of Clostridium difficile infections[J]. Am J Gastroenterol, 2013, 108(4): 478-498.
|